Isolated nucleic acid molecules associated with colon, renal, and stomach cancer and methods of using these
First Claim
Patent Images
1. An isolated nucleic acid molecule selected from the group consisting of:
- (a) nucleic acid molecules which comprise a nucleotide sequence, the complementary sequence of which hybridizes, under stringent conditions, to at least one second nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of the nucleotide sequences set forth as SEQ ID NOs;
8-18, and which encode a tumor associated antigen, (b) nucleic acid molecules that differ from the nucleic acid molecules of (a) in codon sequence due to the degeneracy of the genetic code, and (c) complements of (a) or (b).
2 Assignments
0 Petitions
Accused Products
Abstract
Various molecules associated with cancer are disclosed. The invention also discloses diagnostic and therapeutic methods based upon these molecules.
72 Citations
29 Claims
-
1. An isolated nucleic acid molecule selected from the group consisting of:
-
(a) nucleic acid molecules which comprise a nucleotide sequence, the complementary sequence of which hybridizes, under stringent conditions, to at least one second nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of the nucleotide sequences set forth as SEQ ID NOs;
8-18, and which encode a tumor associated antigen,(b) nucleic acid molecules that differ from the nucleic acid molecules of (a) in codon sequence due to the degeneracy of the genetic code, and (c) complements of (a) or (b). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)
-
- 28. An isolated nucleic acid molecule comprising at least two non-identical nucleotide sequences which encode non-identical peptides, wherein the non-identical nucleotide sequences are selected from the group consisting of nucleotide sequences set forth as SEQ ID NOs:
Specification